![Jeff Miller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Miller
Direktor/Vorstandsmitglied bei
BIOTECanada
Profil
Jeff Miller is a board member at BIOTECanada and a business advisor at Dreavent, Inc. He previously worked as a director at Boehringer Ingelheim GmbH from 2005 to 2009, as a vice president at EMD Serono, Inc. from 2012 to 2014, and as a vice president at Alnylam Pharmaceuticals, Inc. in 2018.
Mr. Miller received his undergraduate degree from State University of New York College at Oswego in 1994 and his MBA from Questrom School of Business in 1996.
Aktive Positionen von Jeff Miller
| Unternehmen | Position | Beginn |
|---|---|---|
Dreavent, Inc.
 Dreavent, Inc. Investment ManagersFinance Dreavent invests in companies located in the United States. The firm targets companies operating in the fields of healthcare, biotech and life science sectors. It provides financing for early and later stage capital requirements. | Berater | 01.03.2023 |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | 01.05.2020 |
Ehemalige bekannte Positionen von Jeff Miller
| Unternehmen | Position | Ende |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Private Equity Investor | 01.06.2018 |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Private Equity Investor | 01.01.2014 |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Corporate Officer/Principal | 01.01.2009 |
Ausbildung von Jeff Miller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
State University of New York College at Oswego
 State University of New York College at Oswego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Questrom School of Business
 Questrom School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent invests in companies located in the United States. The firm targets companies operating in the fields of healthcare, biotech and life science sectors. It provides financing for early and later stage capital requirements. | Finance |
